Blood Pressure Variability in Alzheimer's Disease and Frontotemporal Dementia: The Effect on the Rate of Cognitive Decline

Journal of Alzheimer's Disease

Volumn 45, Issue 2, 2015, Pages 387-394

  Lattanzi, Simona ^a   Luzzi, Simona ^a   Provinciali, Leandro ^a   Silvestrini, Mauro ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Alzheimer's disease; blood pressure; dementia; frontotemporal dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE VARIABILITY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; COGNITION DISORDERS; COMPLICATION; MENTAL HEALTH; MIDDLE AGED; PHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD PRESSURE; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; FRONTOTEMPORAL DEMENTIA; HUMANS; LINEAR MODELS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84925363607     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-142532     Document Type: Article

References (43)

1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: A systematic review and meta analysis. Alzheimers Dement 9, 63-75.
2. de la Torre JC (2012) Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neuro 2012, 367516.
3. Silvestrini M, Viticchi G, Falsetti L, Balucani C, Vernieri F, Cerqua R, Luzzi S, Bartolini M, Provinciali L (2011) The role of carotid atherosclerosis in Alzheimer's disease progression. J Alzheimers Dis 25, 719-726.
4. Silvestrini M, Gobbi B, Pasqualetti P, Bartolini M, Baruffaldi R, Lanciotti C, Cerqua R, Altamura C, Provinciali L, Vernieri F (2009) Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease. Neurobiol Aging 30, 1177-1183.
5. Rothwell PM (2010) Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 375, 938-948.
6. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR (2010) Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375, 895-905.
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
8. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51, 1546-1554.
9. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P (2001) European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32, 1318-1322.
10. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, BretelerMM(1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53, 1937-1942.
11. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Odén A, Svanborg A (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347, 1141-1145.
12. Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG (2007) Vascular factors predict rate of progression in Alzheimer disease. Neurology 69, 1850-1858.
13. Balestrini S, Perozzi C, Altamura C, Vernieri F, Luzzi S, Bartolini M, Provinciali L, Silvestrini M (2013) Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration. Neurology 80, 2145-2150.
14. Viticchi G, Falsetti L, Vernieri F, Altamura C, Bartolini M, Luzzi S, Provinciali L, Silvestrini M. (2012) Vascular predictors of cognitive decline in patients with mild cognitive impairment. Neurobiol Aging 33, 1127 e1-9.
15. Manios E, Stamatelopoulos K, Tsivgoulis G, Barlas G, Koroboki E, Tsagalis G, Michas F, Vemmos K, Zakopoulos NA (2011) Time rate of blood pressure variation: A new factor associated with coronary atherosclerosis. J Hypertens 29, 1109-1114.
16. Manios E, Tsagalis G, Tsivgoulis G, Barlas G, Koroboki E, Michas F, Alexaki E, Vemmos K, Zakopoulos NA (2009) Time rate of blood pressure variation is associated with impaired renal function in hypertensive patients. J Hypertens 27, 2244-2248.
17. Mancia G, Parati G (2003) The role of blood pressure variability in end-organ damage. J Hypertens Suppl 21, S17-S23.
18. Buratti L, Cagnetti C, Balucani C, Viticchi G, Falsetti L, Luzzi S, Lattanzi S, Provinciali L, SilvestriniM(2014) Blood pressure variability and stroke outcome in patients with internal carotid artery occlusion. J Neurol Sci 339, 164-168.
19. Goldstein IB, Bartzokis G, Guthrie D, Shapiro D (2002) Ambulatory blood pressure and brain atrophy in the healthy elderly. Neurology 59, 713-719.
20. Bellelli G, Frisoni GB, Lucchi E, Guerini F, Geroldi C, Magnifico F, Bianchetti A, TrabucchiM(2004) Lack of night-time blood pressure reduction is associated with cognitive deterioration in subjects with long-standing hypertension. Blood Press Monitor 9, 71-76.
21. Kilander L, Nyman H, BobergM, Hansson L, LithellH(1998) Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men. Hypertension 31, 780-786.
22. Ohya Y, Ohtsubo T, Tsuchihashi T, Eto K, Sadanaga T, Nagao T, Abe I, Fujishima M (2001) Altered diurnal variation of blood pressure in elderly subjects with decreased activity of daily living and impaired cognitive functions. Hypertens Res 24, 655-661.
23. Lattanzi S, Luzzi S, Provinciali L, SilvestriniM(2014) Blood pressure variability predicts cognitive decline in Alzheimer's disease patients. Neurobiol Aging 35, 2282-2287.
24. Alpérovitch A, Blachier M, Soumaré A, Ritchie K, Dartigues JF, Richard-Harston S, Tzourio C (2014) Blood pressure variability and risk of dementia in an elderly cohort, the Three-City Study. Alzheimers Dement 10(5 Suppl), S330-S337.
25. Keary TA, Gunstad J, Poppas A, Paul RH, Jefferson AL, Hoth KF, Sweet LH, Forman DE, Cohen RA (2007) Blood pressure variability and dementia rating scale performance in older adults with cardiovascular disease. Cogn Behav Neurol 20, 73-77.
26. Okonkwo OC, Cohen RA, Gunstad J, Poppas A (2011) Cardiac output, blood pressure variability, and cognitive decline in geriatric cardiac patients. J Cardiopulm Rehabil Prev 31, 290-297.
27. Diaz KM, Veerabhadrappa P, Kashem MA, Thakkar SR, Feairheller DL, Sturgeon KM, Ling C, Williamson ST, Kretzschmar J, Lee H, Grimm H, Babbitt DM, Vin C, Fan X, Crabbe DL, Brown MD (2013) Visit-to-visit and 24-h blood pressure variability: Association with endothelial and smooth muscle function in African Americans. J Hum Hypertens 27, 671-677.
28. Alrawi YA, Panerai RB, Myint PK, Potter JF (2013) Pharmacological blood pressure lowering in the older hypertensive patients may lead to cognitive impairment by altering neurovascular coupling. Med Hypotheses 80, 303-307.
29. de laTorre JC (2002) Alzheimer disease as a vascular disorder: Nosological evidence. Stroke 33, 1152-1162.
30. Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, Pirraglia E, De Santi S, Reisberg B, Wisniewski T, de Leon MJ (2009) FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging 36, 811-822.
31. Silvestrini M, Viticchi G, Altamura C, Luzzi S, Balucani C, Vernieri F (2012) Cerebrovascular assessment for the risk prediction of Alzheimer's disease. J Alzheimers Dis 32, 689-698.
32. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
33. Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM (2011) A harmonized classification system for FTLDTDP pathology. Acta Neuropathol 122, 111-113.
34. Rabinovici GD, Miller BL (2010) Frontotemporal lobar degeneration: Epidemiology, pathophysiology, diagnosis and management. CNS Drugs 24, 375-398.
35. Fotuhi M, Hachinski V, Whitehouse PJ (2009) Changing perspectives regarding late-life dementia. Nat Rev Neurol 5, 649-658.
36. Lau KK, Wong YK, Chan YH, Teo KC, Chan KH, Wai Li LS, Cheung RT, Siu CW, Ho SL, Tse HF (2014) Visit-tovisit blood pressure variability as a prognostic marker in patients with cardiovascular and cerebrovascular diseases- relationships and comparisons with vascular markers of atherosclerosis. Atherosclerosis 235, 230-235.
37. Epstein NU, Lane KA, Farlow MR, Risacher SL, Saykin AJ, Gao S (2013) Cognitive dysfunction and greater visit-to-visit systolic blood pressure variability. J AmGeriatr Soc 61, 2168-2173.
38. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S (2011) The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: Findings from NHANES III, 1988 to 1994. Hypertension 57, 160-166.
39. Rabinovici GD, Seeley WW, Kim EJ, Gorno-Tempini ML, Rascovsky K, Pagliaro TA, Allison SC, Halabi C, Kramer JH, Johnson JK, Weiner MW, Forman MS, Trojanowski JQ, Dear-mond SJ, Miller BL, Rosen HJ (2007) Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen 22, 474-488.
40. Rosen HJ, Gorno-Tempini ML, Goldman WP, Perry RJ, Schuff N, Weiner M, Feiwell R, Kramer JH, Miller BL (2002) Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58, 198-208.
41. Lattanzi S, Viticchi G, Falsetti L, Buratti L, Luzzi S, Provinciali L, Silvestrini M (2014) Visit-to-visit blood pressure variability in Alzheimer disease. Alzheimer Dis Assoc Disord 28, 347-351.
42. Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, White LR (2013) Antihypertensive medication use and risk of cognitive impairment: The Honolulu-Asia Aging Study. Neurology 81, 888-895.
43. Yasar S, Xia J, Yao W, Furberg CD, Xue QL, Mercado CI, Fitzpatrick AL, Fried LP, Kawas CH, Sink KM, Williamson JD, DeKosky ST, CarlsonMC(2013) Ginkgo Evaluation of Memory Study Investigators. Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo evaluation of memory study. Neurology 81, 896-903.